EUVIMEDOpdag EUVIMED
Crossref

Ant Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo

Juan Manuel Leyva-Castillo, Christina Huang, Paola Baker, John Bacsa, Raif S Geha, Jack L Arbiser

Journal of Drugs in Dermatology · 2023

DOI: 10.36849/jdd.7308 ↗

At a glance

Journal article in Journal of Drugs in Dermatology, 2023. Written by Juan Manuel Leyva-Castillo and 5 co-authors. Major MEDLINE topics: Dermatitis, Atopic, Ant Venoms, Psoriasis. Cited 3 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Atopic dermatitis (AD) is a common skin condition with relatively few therapeutic alternatives. These include corticosteroids, which address inflammation but not superinfection, and Januse kinase (JAK) inhibitors, which have a US Food and Drug Administration (FDA) black box for potential carcinogenicity. METHODS: We demonstrate that S14, a synthetic derivative of ant venom-derived solenopsin, has potent anti inflammatory effects on the OVA murine model of atopic dermatitis. S14 has demonstrated prior activity in murine psoriasis and has the benefit of ceramide anti-inflammatory effects without being able to be metabolized into proinflammatory sphingosine-1 phosphate. RESULTS: The efficacy of S14 accompanied by the induction of IL-12 suggests a commonality in inflammatory skin disorders, and our results suggest that pharmacological ceramide restoration will be broadly effective for inflammatory skin disease. CONCLUSIONS: Solenopsin derivative S14 has anti-inflammatory effects in murine models of AD and psoriasis. This makes S14 a strong candidate for human use, and pre-IND studies are warranted.J Drugs Dermatol. 2023;22(10):1001-1006 doi:10.36849/JDD.7308.

Subjects

MeSH terms (MEDLINE)

Dermatitis, AtopicAnt VenomsPsoriasisHumansMiceAnimalsCeramidesAnti-Inflammatory Agents

Substances

Ant VenomsCeramidesAnti-Inflammatory Agents

Cite

APA

Leyva-Castillo, J. M., Huang, C., Baker, P., Bacsa, J., Geha, R. S., & Arbiser, J. L. (2023). Ant Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7308

Vancouver

Leyva-Castillo JM, Huang C, Baker P, Bacsa J, Geha RS, Arbiser JL. Ant Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7308

BibTeX
@article{LeyvaCastillo2023,
  author = {Leyva-Castillo, Juan Manuel and Huang, Christina and Baker, Paola and Bacsa, John and Geha, Raif S and Arbiser, Jack L},
  title = {Ant Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo},
  journal = {Journal of Drugs in Dermatology},
  year = {2023},
  doi = {10.36849/jdd.7308}
}
Start for free →